Business
Press Release Feb 04 2026
Zydus Lifesciences Limited has informed the Exchange regarding a press release dated February 04, 2026, titled "Zydus receives tentative approval from USFDA for Dapagliflozin Tablets, 5 mg and 10 mg".
About this update from Zydus Lifesciences Limited
[{"type":"text","content":" Zydus Lifesciences Limited has informed the Exchange regarding a press release dated February 04, 2026, titled \"Zydus receives tentative approval from USFDA for Dapagliflozin Tablets, 5 mg and 10 mg\". View Attachment","length":343,"tagName":"div"}]